Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products

Stock Information for Pharmacielo Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Pharmacielo Ltd.

PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo
PharmaCielo Announces Q3 2023 Financial Results
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement
PharmaCielo Announces Q2 2023 Financial Results
PharmaCielo Provides Corporate Update
PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.